OBJECTIVES: During mass antibiotic distributions for trachoma, certain individuals are difficult to locate and go untreated. These untreated individuals may serve as a source of community reinfection. The importance of this difficult-to-locate, untreated population is unclear. We sought to determine whether individuals who are difficult to locate were more likely to be infected with ocular chlamydia than those who were easier to locate. METHODS: We monitored 12 Ethiopian communities 1 year after a third annual mass azithromycin treatment for trachoma. Conjunctival swabbing for chlamydial RNA was performed in a random sample of children from each community. If insufficient numbers of children were enrolled on the first monitoring day, we returned on subsequent days. RESULTS: Of the 12 communities, 10 required more than one monitoring day. On average, 16.1% (95% CI 7.9-30.0) of children were enrolled after the initial day. Evidence of chlamydia was found in 7.1% (95% CI 2.7-17.4) of 0- to 9-year-old children. No ocular swabs collected after the initial day were positive for chlamydial RNA. Children examined after the initial monitoring day were significantly less likely to have ocular chlamydial infection than children seen on the initial day; Mantel-Haenszel common OR = 0 (95% CI 0-0.77). CONCLUSIONS: In a setting of repeated annual mass azithromycin treatments, after approximately 80% of individuals have been located in a community, extra efforts to find absent individuals may not yield significantly more cases of ocular chlamydia.
OBJECTIVES: During mass antibiotic distributions for trachoma, certain individuals are difficult to locate and go untreated. These untreated individuals may serve as a source of community reinfection. The importance of this difficult-to-locate, untreated population is unclear. We sought to determine whether individuals who are difficult to locate were more likely to be infected with ocular chlamydia than those who were easier to locate. METHODS: We monitored 12 Ethiopian communities 1 year after a third annual mass azithromycin treatment for trachoma. Conjunctival swabbing for chlamydial RNA was performed in a random sample of children from each community. If insufficient numbers of children were enrolled on the first monitoring day, we returned on subsequent days. RESULTS: Of the 12 communities, 10 required more than one monitoring day. On average, 16.1% (95% CI 7.9-30.0) of children were enrolled after the initial day. Evidence of chlamydia was found in 7.1% (95% CI 2.7-17.4) of 0- to 9-year-old children. No ocular swabs collected after the initial day were positive for chlamydial RNA. Children examined after the initial monitoring day were significantly less likely to have ocular chlamydial infection than children seen on the initial day; Mantel-Haenszel common OR = 0 (95% CI 0-0.77). CONCLUSIONS: In a setting of repeated annual mass azithromycin treatments, after approximately 80% of individuals have been located in a community, extra efforts to find absent individuals may not yield significantly more cases of ocular chlamydia.
Authors: Jon L Yang; Julius Schachter; Jeanne Moncada; Dereje Habte; Mulat Zerihun; Jenafir I House; Zhaoxia Zhou; Kevin C Hong; Kathryn Maxey; Bruce D Gaynor; Thomas M Lietman Journal: Br J Ophthalmol Date: 2006-10-18 Impact factor: 4.638
Authors: Teshome Gebre; Berhan Ayele; Mulat Zerihun; Asrat Genet; Nicole E Stoller; Zhaoxia Zhou; Jenafir I House; Sun N Yu; Kathryn J Ray; Paul M Emerson; Jeremy D Keenan; Travis C Porco; Thomas M Lietman; Bruce D Gaynor Journal: Lancet Date: 2011-12-20 Impact factor: 79.321
Authors: Muluken Melese; Jaya Devi Chidambaram; Wondu Alemayehu; David Chung Lee; Elizabeth H Yi; Vicky Cevallos; Zhaoxia Zhou; Cathy Donnellan; Michael Saidel; John P Whitcher; Bruce D Gaynor; Thomas M Lietman Journal: JAMA Date: 2004-08-11 Impact factor: 56.272
Authors: Kathryn J Ray; Travis C Porco; Kevin C Hong; David C Lee; Wondu Alemayehu; Muluken Melese; Takele Lakew; Elizabeth Yi; Jenafir House; Jaya D Chidambaram; John P Whitcher; Bruce D Gaynor; Thomas M Lietman Journal: BMC Infect Dis Date: 2007-08-07 Impact factor: 3.090
Authors: Jeremy D Keenan; Craig W See; Jeanne Moncada; Berhan Ayele; Teshome Gebre; Nicole E Stoller; Charles E McCulloch; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Thomas M Lietman Journal: Invest Ophthalmol Vis Sci Date: 2012-01-25 Impact factor: 4.799
Authors: Abdou Amza; Boubacar Kadri; Baido Nassirou; Sun N Yu; Nicole E Stoller; Satasuk J Bhosai; Zhaoxia Zhou; Charles E McCulloch; Sheila K West; Robin L Bailey; Jeremy D Keenan; Thomas M Lietman; Bruce D Gaynor Journal: PLoS Negl Trop Dis Date: 2013-01-10
Authors: Fengchen Liu; Travis C Porco; Harran A Mkocha; Beatriz Muñoz; Kathryn J Ray; Robin L Bailey; Thomas M Lietman; Sheila K West Journal: Epidemics Date: 2014-01-08 Impact factor: 4.396
Authors: Robert M R Butcher; Oliver Sokana; Kelvin Jack; Colin K Macleod; Michael E Marks; Eric Kalae; Leslie Sui; Charles Russell; Helena J Tutill; Rachel J Williams; Judith Breuer; Rebecca Willis; Richard T Le Mesurier; David C W Mabey; Anthony W Solomon; Chrissy H Roberts Journal: PLoS Negl Trop Dis Date: 2016-09-07